NDC 0173-0859 – Breo Ellipta
Fluticasone Furoate 100 ug/1; Vilanterol Trifenatate 25 ug/1 · Powder · Respiratory (inhalation)
Product NDC0173-0859
Product details
- Brand name
- Breo Ellipta
- Generic name
- Fluticasone furoate and vilanterol trifenatate
- Labeler
- GlaxoSmithKline LLC
- Dosage form
- Powder
- Route
- Respiratory (inhalation)
- Marketing category
- NDA · NDA204275
- Marketed since
- August 26, 2013
- Listing expires
- December 31, 2027
- Pharmacologic class
- Corticosteroid; beta2-Adrenergic Agonist
Active ingredients
- Fluticasone Furoate 100 ug/1
- Vilanterol Trifenatate 25 ug/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0173-0859-10 | 1 TRAY in 1 CARTON (0173-0859-10) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER | Aug 26, 2013 |
| 0173-0859-14 | 1 TRAY in 1 CARTON (0173-0859-14) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER | Aug 26, 2013 |